2004 Computational Chemistry Marketing 
Drug Target Review
SEPTEMBER 20, 2023
Author bio: Matthew Habgood Principal Computational Chemist, Cresset Matthew graduated from Imperial College London in 2004 with an MSci in Chemistry and was co-awardee of the Neil Arnott prize for best chemistry graduate at the University of London. Rob is a Fellow of the Royal Society of Chemistry.
Sygnature Discovery
JULY 31, 2023
This acquisition cements Sygnature as one of the world’s largest players in integrated drug discovery phase solutions and advances their vision to become the global market leader. Since 2004, Sygnature Discovery has delivered over 40 novel pre-clinical and 22 clinical compounds, with its scientists named on over 170 patents.
Expert insights. Personalized for you.
105 
Let's personalize your content